Development of humoral and cellular immunological memory against SARS-CoV-2 despite B-cell depleting treatment in multiple sclerosis. Asplund Högelin et al.
Published: 24 August 2021| Version 1 | DOI: 10.17632/59z3rn4x6p.1
Contributor:
Faiez Al NimerDescription
Supplementary Table 1. Detailed characteristics of the study cohort.
Files
Categories
Immunology, Rituximab, Multiple Sclerosis, COVID-19